VC-backed Agile Therapeutics files for IPO

Agile Therapeutics has filed for an IPO. The number of shares that will be offered as well as the pricing terms of the stock have yet to be set. RBC Capital Markets and William Blair & Company will serve as the lead underwriters. Based in Princeton, NJ, Agile Therapeutics is a women’s health specialty pharmaceutical company focused on developing prescription contraceptives. Its backers include Aisling Capital, Care Capital, Investor Growth Capital, ProQuest Investments, Kaiser Permanente Ventures and Novitas Capital.

PRESS RELEASE

PRINCETON, N.J., March 17, 2014 /PRNewswire/ — Agile Therapeutics, Inc., a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by Agile Therapeutics, Inc. The number of shares to be offered and the price range for the offering have not yet been determined.
RBC Capital Markets, LLC and William Blair & Company, L.L.C. are acting as joint book-running managers for the offering. Cantor Fitzgerald & Co. and Janney Montgomery Scott LLC are acting as co-managers.
A registration statement relating to these securities has been filed with the SEC, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy and there shall not be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
The offering will be made only by means of a prospectus. When available, a copy of the preliminary prospectus relating to and describing the terms of the offering may be obtained from RBC Capital Markets, LLC, Attention: Equity Syndicate, Three World Financial Center, 200 Vesey Street, 8th Floor, New York, New York 10281 and William Blair & Company, L.L.C., Attention: Prospectus Department, 222 West Adams Street, Chicago, IL 60606, Telephone: (800) 621-0687.

Related Posts

Leave a Reply

PEHUB Community

Join the 12503 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget